Tirzepatide

Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are hormones involved in blood sugar control. Tirzepatide is a first-in-class medication that activates both the GLP-1 and GIP receptors. It is a GIP-analogue that activates both the GLP-1 and GIP receptors, leading to improved blood sugar control.

How is it different from Semaglutide?

• Tirzepatide has a greater affinity to GIP receptors than to GLP-1 receptors, and this dual agonist behavior has been shown to produce greater reductions of hyperglycemia compared to a selective GLP-1 receptor agonist.

Formulations available at LRC:

Tirzepatide/BPC-157/B6

Once a week injection

BPC-157, composed of 15 amino acids, is a partial sequence of body protection compound (BPC) that is discovered in and isolated from human gastric juice. It has been demonstrated to accelerate the healing of many different injuries, including tendons, muscles, nervous system and superior healing of damaged ligaments. BPC-157 aids in overall tissue repair by increasing blood flow to your damaged tissues. It is also an anti-inflammatory, meaning it aids in the production and healing of your inflamed intestinal tissues.

Vitamin B6 is a vitamin that benefits the central nervous system and metabolism. Its roles include turning food into energy and helping to create neurotransmitters, such as serotonin and dopamine. It has also been known to aid in decreasing nausea symptoms. Some studies show negative side effects of Semaglutide may include nausea, diarrhea and even vomiting. The addition of BPC-157 and B6 can help decrease/prevent these symptoms.

Tirzepatide/B12

Once a week injection

B12 works by converting the food we eat into sugar and other types of fuel that keep the body running smoothly. B12 is often associated with weight loss because of its ability to boost metabolism and provide lasting energy.

Book Appointment